Cargando…
The WNT Pathway Is Relevant for the BCR-ABL1-Independent Resistance in Chronic Myeloid Leukemia
Notwithstanding the introduction of Tyrosine Kinase Inhibitors (TKIs) revolutionized the outcome of Chronic Myeloid Leukemia (CML), one third of patients still suspends treatment for failure response. Recent research demonstrated that several BCR/ABL1-independent mechanisms can sustain resistance, b...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6601352/ https://www.ncbi.nlm.nih.gov/pubmed/31293972 http://dx.doi.org/10.3389/fonc.2019.00532 |
_version_ | 1783431283205996544 |
---|---|
author | Grassi, Susanna Palumbo, Sara Mariotti, Veronica Liberati, Diego Guerrini, Francesca Ciabatti, Elena Salehzadeh, Serena Baratè, Claudia Balducci, Serena Ricci, Federica Buda, Gabriele Iovino, Lorenzo Mazziotta, Francesco Ghio, Francesco Ercolano, Giacomo Di Paolo, Antonello Cecchettini, Antonella Baldini, Chiara Mattii, Letizia Pellegrini, Silvia Petrini, Mario Galimberti, Sara |
author_facet | Grassi, Susanna Palumbo, Sara Mariotti, Veronica Liberati, Diego Guerrini, Francesca Ciabatti, Elena Salehzadeh, Serena Baratè, Claudia Balducci, Serena Ricci, Federica Buda, Gabriele Iovino, Lorenzo Mazziotta, Francesco Ghio, Francesco Ercolano, Giacomo Di Paolo, Antonello Cecchettini, Antonella Baldini, Chiara Mattii, Letizia Pellegrini, Silvia Petrini, Mario Galimberti, Sara |
author_sort | Grassi, Susanna |
collection | PubMed |
description | Notwithstanding the introduction of Tyrosine Kinase Inhibitors (TKIs) revolutionized the outcome of Chronic Myeloid Leukemia (CML), one third of patients still suspends treatment for failure response. Recent research demonstrated that several BCR/ABL1-independent mechanisms can sustain resistance, but the relationship between these mechanisms and the outcome has not yet been fully understood. This study was designed to evaluate in a “real-life” setting if a change of expression of several genes involved in the WNT/BETA-CATENIN, JAK-STAT, and POLYCOMB pathways might condition the outcome of CML patients receiving TKIs. Thus, the expression of 255 genes, related to the aforementioned pathways, was measured by quantitative PCR after 6 months of therapy and compared with levels observed at diagnosis in 11 CML patients, in order to find possible correlations with quality of response to treatment and event-free-survival (EFS). These results were then re-analyzed by the principal component method (PCA) for tempting to better cluster resistant cases. After 12 months of therapy, 6 patients achieved an optimal response and 5 were “resistant;” after application of both statistical methods, it was evident that in all pathways a significant overall up-regulation occurred, and that WNT was the pathway mostly responsible for the TKIs resistance. Indeed, 100% of patients with a “low” up-regulation of this pathway achieved an optimal response vs. 33% of those who showed a “high” gene over-expression (p = 0.016). Analogously, the 24-months EFS resulted significantly influenced by the degree of up-regulation of the WNT signaling: all patients with a “low” up-regulation were event-free vs. 33% of those who presented a “high” gene expression (p = 0.05). In particular, the PCA analysis confirmed the role of WNT pathway and showed that the most significantly up-regulated genes with negative prognostic value were DKK, WNT6, WISP1, and FZD8. In conclusion, our results sustain the need of a wide and multitasking approach in order to understand the resistance mechanisms in CML. |
format | Online Article Text |
id | pubmed-6601352 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-66013522019-07-10 The WNT Pathway Is Relevant for the BCR-ABL1-Independent Resistance in Chronic Myeloid Leukemia Grassi, Susanna Palumbo, Sara Mariotti, Veronica Liberati, Diego Guerrini, Francesca Ciabatti, Elena Salehzadeh, Serena Baratè, Claudia Balducci, Serena Ricci, Federica Buda, Gabriele Iovino, Lorenzo Mazziotta, Francesco Ghio, Francesco Ercolano, Giacomo Di Paolo, Antonello Cecchettini, Antonella Baldini, Chiara Mattii, Letizia Pellegrini, Silvia Petrini, Mario Galimberti, Sara Front Oncol Oncology Notwithstanding the introduction of Tyrosine Kinase Inhibitors (TKIs) revolutionized the outcome of Chronic Myeloid Leukemia (CML), one third of patients still suspends treatment for failure response. Recent research demonstrated that several BCR/ABL1-independent mechanisms can sustain resistance, but the relationship between these mechanisms and the outcome has not yet been fully understood. This study was designed to evaluate in a “real-life” setting if a change of expression of several genes involved in the WNT/BETA-CATENIN, JAK-STAT, and POLYCOMB pathways might condition the outcome of CML patients receiving TKIs. Thus, the expression of 255 genes, related to the aforementioned pathways, was measured by quantitative PCR after 6 months of therapy and compared with levels observed at diagnosis in 11 CML patients, in order to find possible correlations with quality of response to treatment and event-free-survival (EFS). These results were then re-analyzed by the principal component method (PCA) for tempting to better cluster resistant cases. After 12 months of therapy, 6 patients achieved an optimal response and 5 were “resistant;” after application of both statistical methods, it was evident that in all pathways a significant overall up-regulation occurred, and that WNT was the pathway mostly responsible for the TKIs resistance. Indeed, 100% of patients with a “low” up-regulation of this pathway achieved an optimal response vs. 33% of those who showed a “high” gene over-expression (p = 0.016). Analogously, the 24-months EFS resulted significantly influenced by the degree of up-regulation of the WNT signaling: all patients with a “low” up-regulation were event-free vs. 33% of those who presented a “high” gene expression (p = 0.05). In particular, the PCA analysis confirmed the role of WNT pathway and showed that the most significantly up-regulated genes with negative prognostic value were DKK, WNT6, WISP1, and FZD8. In conclusion, our results sustain the need of a wide and multitasking approach in order to understand the resistance mechanisms in CML. Frontiers Media S.A. 2019-06-24 /pmc/articles/PMC6601352/ /pubmed/31293972 http://dx.doi.org/10.3389/fonc.2019.00532 Text en Copyright © 2019 Grassi, Palumbo, Mariotti, Liberati, Guerrini, Ciabatti, Salehzadeh, Baratè, Balducci, Ricci, Buda, Iovino, Mazziotta, Ghio, Ercolano, Di Paolo, Cecchettini, Baldini, Mattii, Pellegrini, Petrini and Galimberti. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Grassi, Susanna Palumbo, Sara Mariotti, Veronica Liberati, Diego Guerrini, Francesca Ciabatti, Elena Salehzadeh, Serena Baratè, Claudia Balducci, Serena Ricci, Federica Buda, Gabriele Iovino, Lorenzo Mazziotta, Francesco Ghio, Francesco Ercolano, Giacomo Di Paolo, Antonello Cecchettini, Antonella Baldini, Chiara Mattii, Letizia Pellegrini, Silvia Petrini, Mario Galimberti, Sara The WNT Pathway Is Relevant for the BCR-ABL1-Independent Resistance in Chronic Myeloid Leukemia |
title | The WNT Pathway Is Relevant for the BCR-ABL1-Independent Resistance in Chronic Myeloid Leukemia |
title_full | The WNT Pathway Is Relevant for the BCR-ABL1-Independent Resistance in Chronic Myeloid Leukemia |
title_fullStr | The WNT Pathway Is Relevant for the BCR-ABL1-Independent Resistance in Chronic Myeloid Leukemia |
title_full_unstemmed | The WNT Pathway Is Relevant for the BCR-ABL1-Independent Resistance in Chronic Myeloid Leukemia |
title_short | The WNT Pathway Is Relevant for the BCR-ABL1-Independent Resistance in Chronic Myeloid Leukemia |
title_sort | wnt pathway is relevant for the bcr-abl1-independent resistance in chronic myeloid leukemia |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6601352/ https://www.ncbi.nlm.nih.gov/pubmed/31293972 http://dx.doi.org/10.3389/fonc.2019.00532 |
work_keys_str_mv | AT grassisusanna thewntpathwayisrelevantforthebcrabl1independentresistanceinchronicmyeloidleukemia AT palumbosara thewntpathwayisrelevantforthebcrabl1independentresistanceinchronicmyeloidleukemia AT mariottiveronica thewntpathwayisrelevantforthebcrabl1independentresistanceinchronicmyeloidleukemia AT liberatidiego thewntpathwayisrelevantforthebcrabl1independentresistanceinchronicmyeloidleukemia AT guerrinifrancesca thewntpathwayisrelevantforthebcrabl1independentresistanceinchronicmyeloidleukemia AT ciabattielena thewntpathwayisrelevantforthebcrabl1independentresistanceinchronicmyeloidleukemia AT salehzadehserena thewntpathwayisrelevantforthebcrabl1independentresistanceinchronicmyeloidleukemia AT barateclaudia thewntpathwayisrelevantforthebcrabl1independentresistanceinchronicmyeloidleukemia AT balducciserena thewntpathwayisrelevantforthebcrabl1independentresistanceinchronicmyeloidleukemia AT riccifederica thewntpathwayisrelevantforthebcrabl1independentresistanceinchronicmyeloidleukemia AT budagabriele thewntpathwayisrelevantforthebcrabl1independentresistanceinchronicmyeloidleukemia AT iovinolorenzo thewntpathwayisrelevantforthebcrabl1independentresistanceinchronicmyeloidleukemia AT mazziottafrancesco thewntpathwayisrelevantforthebcrabl1independentresistanceinchronicmyeloidleukemia AT ghiofrancesco thewntpathwayisrelevantforthebcrabl1independentresistanceinchronicmyeloidleukemia AT ercolanogiacomo thewntpathwayisrelevantforthebcrabl1independentresistanceinchronicmyeloidleukemia AT dipaoloantonello thewntpathwayisrelevantforthebcrabl1independentresistanceinchronicmyeloidleukemia AT cecchettiniantonella thewntpathwayisrelevantforthebcrabl1independentresistanceinchronicmyeloidleukemia AT baldinichiara thewntpathwayisrelevantforthebcrabl1independentresistanceinchronicmyeloidleukemia AT mattiiletizia thewntpathwayisrelevantforthebcrabl1independentresistanceinchronicmyeloidleukemia AT pellegrinisilvia thewntpathwayisrelevantforthebcrabl1independentresistanceinchronicmyeloidleukemia AT petrinimario thewntpathwayisrelevantforthebcrabl1independentresistanceinchronicmyeloidleukemia AT galimbertisara thewntpathwayisrelevantforthebcrabl1independentresistanceinchronicmyeloidleukemia AT grassisusanna wntpathwayisrelevantforthebcrabl1independentresistanceinchronicmyeloidleukemia AT palumbosara wntpathwayisrelevantforthebcrabl1independentresistanceinchronicmyeloidleukemia AT mariottiveronica wntpathwayisrelevantforthebcrabl1independentresistanceinchronicmyeloidleukemia AT liberatidiego wntpathwayisrelevantforthebcrabl1independentresistanceinchronicmyeloidleukemia AT guerrinifrancesca wntpathwayisrelevantforthebcrabl1independentresistanceinchronicmyeloidleukemia AT ciabattielena wntpathwayisrelevantforthebcrabl1independentresistanceinchronicmyeloidleukemia AT salehzadehserena wntpathwayisrelevantforthebcrabl1independentresistanceinchronicmyeloidleukemia AT barateclaudia wntpathwayisrelevantforthebcrabl1independentresistanceinchronicmyeloidleukemia AT balducciserena wntpathwayisrelevantforthebcrabl1independentresistanceinchronicmyeloidleukemia AT riccifederica wntpathwayisrelevantforthebcrabl1independentresistanceinchronicmyeloidleukemia AT budagabriele wntpathwayisrelevantforthebcrabl1independentresistanceinchronicmyeloidleukemia AT iovinolorenzo wntpathwayisrelevantforthebcrabl1independentresistanceinchronicmyeloidleukemia AT mazziottafrancesco wntpathwayisrelevantforthebcrabl1independentresistanceinchronicmyeloidleukemia AT ghiofrancesco wntpathwayisrelevantforthebcrabl1independentresistanceinchronicmyeloidleukemia AT ercolanogiacomo wntpathwayisrelevantforthebcrabl1independentresistanceinchronicmyeloidleukemia AT dipaoloantonello wntpathwayisrelevantforthebcrabl1independentresistanceinchronicmyeloidleukemia AT cecchettiniantonella wntpathwayisrelevantforthebcrabl1independentresistanceinchronicmyeloidleukemia AT baldinichiara wntpathwayisrelevantforthebcrabl1independentresistanceinchronicmyeloidleukemia AT mattiiletizia wntpathwayisrelevantforthebcrabl1independentresistanceinchronicmyeloidleukemia AT pellegrinisilvia wntpathwayisrelevantforthebcrabl1independentresistanceinchronicmyeloidleukemia AT petrinimario wntpathwayisrelevantforthebcrabl1independentresistanceinchronicmyeloidleukemia AT galimbertisara wntpathwayisrelevantforthebcrabl1independentresistanceinchronicmyeloidleukemia |